Amgen’s monthly weight loss drug MariTide demonstrated a 20% average body weight reduction in a phase 2 trial, positioning it as a potential competitor in the GLP-1 market dominated by Novo Nordisk and Eli Lilly. With added benefits like improved A1c levels and cardiovascular risk factors, MariTide aims for a phase 3 trial, highlighting advancements in diabetes and weight loss treatments.
Need More Context? 🔎
Video shows Minnesota lawmaker murder suspect speaking at Congo church in 2022
Video footage has emerged of Vance Boelter, the suspect in the Minnesota lawmaker shootings, passionately speaking at a 2022 seminar in the Democratic Republic of the Congo, expressing excitement about his faith. Various organizations, including Global Minnesota and Minnesota Africans United, have clarified that Boelter was not affiliated with them and have condemned the violence surrounding the recent allegations against him. Need More Context? 🔎
Read more